|
CA1202840A
(en)
|
1985-06-10 |
1986-04-08 |
Jonathan R. Kleinsasser |
Combination wet and dry feeder for animals
|
|
JPS63152393A
(ja)
|
1986-07-03 |
1988-06-24 |
Takeda Chem Ind Ltd |
グリコシル誘導体
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US5714585A
(en)
|
1987-10-26 |
1998-02-03 |
Sterling Winthrop, Inc. |
Antibodies that are immunoreactive with interleukin-7
|
|
US5032396A
(en)
|
1989-02-17 |
1991-07-16 |
Immunex Corporation |
IL-7 to stimulate platelet production
|
|
US5231012A
(en)
|
1989-06-28 |
1993-07-27 |
Schering Corporation |
Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)
|
|
US6217857B1
(en)
|
1989-06-28 |
2001-04-17 |
Schering Corporation |
Cytokine synthesis inhibitory factor (IL-10) and pharmaceutical compositions thereof
|
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
DK0567586T3
(da)
|
1991-01-16 |
1995-12-04 |
Schering Corp |
Anvendelse af interleukin-10 ved adoptiv immunterapi af cancer
|
|
DE69201128T2
(de)
|
1991-01-16 |
1995-05-24 |
Schering Corp |
Behandlung von neoplastischen krankenheiten mit interleukin-10.
|
|
US5624823A
(en)
|
1991-11-22 |
1997-04-29 |
The General Hospital Corporation |
DNA encoding procine interleukin-10
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
CA2155109A1
(en)
|
1993-02-01 |
1994-08-18 |
Daniel Abramowicz |
Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
|
|
US5328989A
(en)
|
1993-03-05 |
1994-07-12 |
Schering-Plough |
Purification of human interleukin-10 from a cell culture medium
|
|
US5552303A
(en)
|
1993-03-08 |
1996-09-03 |
Immunex Corporation |
DNA encoding epithelium-derived T-cell factor
|
|
WO1994022473A1
(en)
|
1993-04-01 |
1994-10-13 |
University Of Washington |
Use of interleukin 7 to improve vaccine potency
|
|
US5665345A
(en)
|
1993-05-24 |
1997-09-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods of inhibiting viral replication using IL-10
|
|
IL110413A0
(en)
|
1993-07-26 |
1994-10-21 |
Schering Corp |
Agonists and antagonists of human interleukin-10
|
|
GB9317618D0
(en)
|
1993-08-24 |
1993-10-06 |
Royal Free Hosp School Med |
Polymer modifications
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
|
EP0740552A1
(en)
|
1994-01-20 |
1996-11-06 |
Schering Corporation |
Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
|
|
US5696234A
(en)
|
1994-08-01 |
1997-12-09 |
Schering Corporation |
Muteins of mammalian cytokine interleukin-13
|
|
US5650234A
(en)
|
1994-09-09 |
1997-07-22 |
Surface Engineering Technologies, Division Of Innerdyne, Inc. |
Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
US6410008B1
(en)
|
1994-12-12 |
2002-06-25 |
Beth Israel Hospital Association |
Chimeric IL-10 proteins and uses thereof
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5866134A
(en)
|
1995-03-24 |
1999-02-02 |
Schering Corporation |
Method for enhancing the antibody response to specific antigens with Interleukin-10
|
|
US5770190A
(en)
|
1995-07-14 |
1998-06-23 |
Schering Corporation |
Method of treatment of acute leukemia with inteleukin-10
|
|
GB2304047A
(en)
|
1995-08-09 |
1997-03-12 |
Univ Manchester |
Pharmaceutical compositions containing cytokines
|
|
US5744451A
(en)
|
1995-09-12 |
1998-04-28 |
Warner-Lambert Company |
N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
|
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
|
US5759859A
(en)
|
1996-07-15 |
1998-06-02 |
United States Of America As Represented By The Secretary Of The Army |
Sensor and method for detecting trace underground energetic materials
|
|
US5945097A
(en)
|
1996-09-06 |
1999-08-31 |
Schering Corporation |
Method for lowering cholesterol levels with interleukin-10
|
|
US5989867A
(en)
|
1996-09-23 |
1999-11-23 |
Knappe; Andrea |
DNA encoding IL-10-like homologue; related reagents
|
|
US6660258B1
(en)
|
1997-05-09 |
2003-12-09 |
Pharma Pacific Pty Ltd |
Oromucosal cytokine compositions and uses thereof
|
|
ATE375363T1
(de)
|
1997-07-14 |
2007-10-15 |
Bolder Biotechnology Inc |
Derivate des wachstumshormons und verwandte proteine
|
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
|
ES2211033T3
(es)
|
1998-01-07 |
2004-07-01 |
Debio Recherche Pharmaceutique S.A. |
Acrilatos de polietilenglicol heterobifuncionales degradables y geles y conjugados derivados de dichos acrilatos.
|
|
US6428985B1
(en)
|
1998-12-02 |
2002-08-06 |
The Regents Of The University Of Michigan |
Immunosuppressive structural definition of IL-10
|
|
JP2002532556A
(ja)
|
1998-12-22 |
2002-10-02 |
シェリング・コーポレーション |
Ｃ型肝炎ウイルス感染のインターロイキン−１０での処置
|
|
US7666400B2
(en)
|
2005-04-06 |
2010-02-23 |
Ibc Pharmaceuticals, Inc. |
PEGylation by the dock and lock (DNL) technique
|
|
WO2001005821A2
(en)
|
1999-07-16 |
2001-01-25 |
Maria Teresa Bejarano |
Viral il-10 for the inhibition of angiogenesis, tumorigenesis and metastasis
|
|
US6989377B2
(en)
|
1999-12-21 |
2006-01-24 |
Wisconsin Alumni Research Foundation |
Treating vitamin D responsive diseases
|
|
AU2001231532A1
(en)
|
2000-02-11 |
2001-08-20 |
Maxygen Aps |
Improved interleukin 10
|
|
US20030186386A1
(en)
|
2000-02-11 |
2003-10-02 |
Hansen Christian Karsten |
Interleukin 10
|
|
US7052686B2
(en)
|
2000-09-29 |
2006-05-30 |
Schering Corporation |
Pegylated interleukin-10
|
|
JP2002142770A
(ja)
|
2000-11-08 |
2002-05-21 |
Dnavec Research Inc |
循環系への遺伝子送達用パラミクソウイルスベクター
|
|
US6838452B2
(en)
|
2000-11-24 |
2005-01-04 |
Vascular Biogenics Ltd. |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
|
EP1234583A1
(en)
|
2001-02-23 |
2002-08-28 |
F. Hoffmann-La Roche Ag |
PEG-conjugates of HGF-NK4
|
|
AU2002307497A1
(en)
|
2001-04-23 |
2002-11-05 |
The Regents Of The University Of California |
Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
|
|
GB0212648D0
(en)
|
2002-05-31 |
2002-07-10 |
Immunoclin Lab Ltd |
Treatment with cytokines
|
|
EP1391513A1
(en)
|
2002-08-08 |
2004-02-25 |
Cytheris |
IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
|
|
WO2004022593A2
(en)
|
2002-09-09 |
2004-03-18 |
Nautilus Biotech |
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
|
|
WO2004044006A1
(en)
|
2002-11-14 |
2004-05-27 |
Maxygen, Inc. |
Conjugates of interleukin-10 and polymers
|
|
DK1565183T3
(da)
|
2002-11-29 |
2008-12-01 |
Maria Grazia Roncarolo |
Rapamycin og IL-10 til behandling af autoimmune sygdomme
|
|
WO2004056850A2
(en)
|
2002-12-19 |
2004-07-08 |
Vib Vzw |
Mutant proteins showing increased secretion
|
|
ES2367430T3
(es)
|
2002-12-23 |
2011-11-03 |
Wyeth Llc |
Anticuerpos contra pd-1 y sus usos.
|
|
RS20050501A
(sr)
|
2002-12-26 |
2007-08-03 |
Mountain View Pharmaceuticals Inc., |
Polimerni konjugati citokina,hemokina,faktora rasta, polipeptidnih hormona i njihovih antagonista sa očuvanom aktivnošću vezivanja receptora
|
|
ES2557286T3
(es)
|
2003-03-03 |
2016-01-25 |
Dyax Corp. |
Usos de péptidos que se unen específicamente al receptor del HGF (cMet)
|
|
EP1613274B1
(en)
|
2003-04-15 |
2010-03-03 |
GlaxoSmithKline LLC |
Human il-18 substitution mutants and their conjugates
|
|
US7261882B2
(en)
|
2003-06-23 |
2007-08-28 |
Reagents Of The University Of Colorado |
Methods for treating neuropathic pain by administering IL-10 polypeptides
|
|
JPWO2005033307A1
(ja)
|
2003-09-30 |
2006-12-14 |
技術研究組合 生物分子工学研究所 |
新規のリフォールディング方法およびその方法によって得られたタンパク質
|
|
EP1702068B1
(en)
|
2003-11-28 |
2010-02-10 |
The University Of Sydney |
Latent phase viral interleukin-10-(vii-10) and uses thereof
|
|
KR101163424B1
(ko)
|
2003-12-30 |
2012-07-13 |
메르크 파텐트 게엠베하 |
Ｉｌ－７ 융합 단백질
|
|
US20060078942A1
(en)
|
2004-03-10 |
2006-04-13 |
Pepgen Corporation |
Method of treatment using interferon-tau
|
|
EP2336192A1
(en)
|
2004-03-11 |
2011-06-22 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
|
|
SI2409713T1
(sl)
|
2004-08-10 |
2015-10-30 |
Genzyme Corporation |
Oligonukleotidi za uporabo pri uravnavanju nivojev lipoproteinov in holesterola pri ljudeh
|
|
US20060046961A1
(en)
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
|
CN100334112C
(zh)
|
2004-10-15 |
2007-08-29 |
上海海欣生物技术有限公司 |
人白细胞介素15与Fc融合蛋白
|
|
CN101072793B
(zh)
|
2004-12-09 |
2012-06-20 |
默克专利有限公司 |
具有降低的免疫原性的il-7变体
|
|
GB0500643D0
(en)
|
2005-01-13 |
2005-02-23 |
Renovo Ltd |
Medicaments
|
|
WO2006094530A1
(en)
|
2005-03-11 |
2006-09-14 |
Siegfried Ltd. |
Di-polymer protein conjugates and processes for their preparation
|
|
UY29460A1
(es)
|
2005-04-08 |
2006-11-30 |
Noxxon Pharma Ag |
Acidos nucleicos de union a ghrelin
|
|
EP1901769A2
(en)
|
2005-05-02 |
2008-03-26 |
Avigen, Inc. |
Use of cytokine-derived peptides in treatment of pain and neurodegenerative disease
|
|
EP3530736A3
(en)
*
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
DE602006011311D1
(de)
|
2005-05-31 |
2010-02-04 |
Univ Colorado |
Il-10 mutante
|
|
EP2343363A1
(en)
|
2005-07-01 |
2011-07-13 |
John Schrader |
Methods of isolating cells and generating monoclonal antibodies involving single epitope multiple staining
|
|
EP1746161A1
(en)
|
2005-07-20 |
2007-01-24 |
Cytheris |
Glycosylated IL-7, preparation and uses
|
|
JP5364375B2
(ja)
|
2005-10-04 |
2013-12-11 |
ザイモジェネティクス リミテッド ライアビリティ カンパニー |
Ｉｌ−２９の生産および精製の方法
|
|
WO2007061657A2
(en)
|
2005-11-14 |
2007-05-31 |
The Brigham & Women's Hospital, Inc. |
Interleukin-10 compositions for the treatment of adenocarcinomas
|
|
WO2007087576A2
(en)
|
2006-01-24 |
2007-08-02 |
The Uab Research Foundation |
Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
|
|
US7662965B2
(en)
*
|
2006-01-26 |
2010-02-16 |
Cornerstone Therapeutics, Inc. |
Anabaseine derivatives, pharmaceutical compositions and method of use thereof
|
|
NZ597098A
(en)
*
|
2006-09-28 |
2013-05-31 |
Merck Sharp & Dohme |
Use of pegylated il-10 to treat cancer
|
|
US20100068147A1
(en)
|
2006-10-05 |
2010-03-18 |
Agency for Science , Technology and Research |
Dengue diagnosis and treatment
|
|
JP5220025B2
(ja)
|
2006-12-04 |
2013-06-26 |
プロメディオール， インコーポレイテッド |
線維症疾患を処置するための併用療法
|
|
US8067532B2
(en)
|
2007-01-19 |
2011-11-29 |
Kai Pharmaceuticals, Inc. |
Modifications of peptide compositions to increase stability and delivery efficiency
|
|
US20090028857A1
(en)
|
2007-07-23 |
2009-01-29 |
Cell Genesys, Inc. |
Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
|
|
DE08786222T1
(de)
|
2007-07-31 |
2010-11-25 |
Affibody Ab |
Neue albuminbindende zusammensetzungen, verfahren und anwendungen
|
|
WO2009036568A1
(en)
|
2007-09-19 |
2009-03-26 |
University Health Network |
Methods and compositions for treating tumors and viral infections
|
|
EP2200649A4
(en)
|
2007-10-19 |
2012-09-26 |
Univ California |
COMPOSITIONS AND METHODS FOR TREATING CNS INFUSION, PSYCHOSIS, DELIRE, PTSD OR PTSS
|
|
WO2009062151A1
(en)
|
2007-11-08 |
2009-05-14 |
Cytimmune Sciences, Inc. |
Compositions and methods for generating antibodies
|
|
GB0724231D0
(en)
|
2007-12-12 |
2008-01-30 |
Renono Ltd |
Methods for inhibiting scarring
|
|
AU2009255357A1
(en)
|
2008-05-29 |
2009-12-10 |
Bristol-Myers Squibb Company |
Methods for predicting patient response to modulation of the co-stimulatory pathway
|
|
WO2010022227A1
(en)
|
2008-08-20 |
2010-02-25 |
Schering Corporation |
Methods for monitoring il-10 therapy
|
|
CN102282168A
(zh)
|
2008-11-18 |
2011-12-14 |
梅里麦克制药股份有限公司 |
人血清白蛋白接头以及其结合物
|
|
ES2957546T3
(es)
*
|
2008-12-17 |
2024-01-22 |
Merck Sharp & Dohme |
Producción de mono- y di-PEG-IL10; y usos
|
|
EP2464661B1
(en)
*
|
2009-08-13 |
2018-01-17 |
The Johns Hopkins University |
Methods of modulating immune function with anti-b7-h7cr antibodies
|
|
WO2011044186A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
|
US8435516B2
(en)
|
2009-10-12 |
2013-05-07 |
Pfizer Inc. |
Cancer treatment
|
|
AU2010311332B2
(en)
|
2009-10-30 |
2015-04-23 |
Albumedix Ltd. |
Albumin variants
|
|
AU2010323037B2
(en)
|
2009-11-30 |
2015-01-29 |
Biotest Ag |
Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE)
|
|
US8993524B2
(en)
*
|
2010-03-05 |
2015-03-31 |
The Johns Hopkins University |
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
|
|
BR112012032206A2
(pt)
|
2010-06-16 |
2016-10-04 |
Abbvie Inc |
comparações de amostras de proteínas
|
|
US9163087B2
(en)
|
2010-06-18 |
2015-10-20 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions
|
|
BR112013000452A2
(pt)
|
2010-07-09 |
2020-02-11 |
Affibody Ab |
Polipeptídeo de ligação de albumina, proteína de fusão ou conjugado, polinucleotídeo, método para produzir um polipeptídeo, composição, método para a preparação de uma composição, e, método para aumentar a solubilidade de um composto
|
|
US8759617B2
(en)
|
2010-09-21 |
2014-06-24 |
National Institute Of Agrobiological Sciences |
Method for extraction and purification of recombinant proteins from transgenic plants
|
|
MX349054B
(es)
|
2010-09-28 |
2017-07-07 |
Aegerion Pharmaceuticals Inc |
Leptinas altamente solubles.
|
|
BR112013007442A2
(pt)
|
2010-09-28 |
2019-09-24 |
Amylin Pharmaceuticals Llc |
polipeptídeos construídos tendo duração de ação realçada
|
|
US8895537B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating cardiovascular diseases
|
|
WO2012129514A1
(en)
|
2011-03-23 |
2012-09-27 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
CN102145178B
(zh)
|
2011-04-15 |
2012-09-26 |
北京凯因科技股份有限公司 |
Peg化白介素15
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
US20140242081A1
(en)
*
|
2011-07-18 |
2014-08-28 |
Micromet Ag |
Dosing regimens for treatment of cea-expressing cancers
|
|
EP2768856A4
(en)
|
2011-10-18 |
2015-05-27 |
Prolynx Llc |
PEG CONJUGATES OF EXENATIDE
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
KR20140125803A
(ko)
|
2012-01-26 |
2014-10-29 |
암젠 인크 |
성장 분화 인자 15(gdf-15) 폴리펩타이드들
|
|
US20150038678A1
(en)
|
2012-02-29 |
2015-02-05 |
Ambrx, Inc. |
Interleukin-10 Polypeptide Conjugates and Their Uses
|
|
WO2013169971A1
(en)
*
|
2012-05-10 |
2013-11-14 |
Bristol-Myers Squibb Company |
Anti-tumor antibodies as predictive or prognostic biomarkers of efficacy and survival in ipilimumab-treated patients
|
|
EP2947111B1
(en)
|
2013-01-17 |
2018-03-07 |
Xiamen Sinopeg Biotech Co., Ltd. |
Monofunctional branched polyethyleneglycol and bio-related substance modified by same
|
|
EP2986306A4
(en)
|
2013-04-18 |
2016-12-07 |
Armo Biosciences Inc |
METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
|
|
JP2016526014A
(ja)
|
2013-04-24 |
2016-09-01 |
アルモ・バイオサイエンシーズ・インコーポレイテッド |
インターロイキン−１０組成物及びその使用
|
|
CA2914837A1
(en)
|
2013-06-17 |
2014-12-24 |
Armo Biosciences, Inc. |
Method for assessing protein identity and stability
|
|
US10010588B2
(en)
|
2013-08-30 |
2018-07-03 |
Armo Biosciences, Inc. |
Methods of using pegylated interleukin-10 for treating hyperlipidemia
|
|
KR20160079114A
(ko)
|
2013-11-11 |
2016-07-05 |
아르모 바이오사이언시스 인코포레이티드 |
질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법
|
|
WO2015108785A1
(en)
|
2014-01-15 |
2015-07-23 |
Armo Biosciences, Inc. |
Methods of using interleukin-10 for treating diseases and disorders
|
|
EP3097117B1
(en)
|
2014-01-21 |
2023-10-04 |
Novartis Ag |
Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules
|
|
MA39711A
(fr)
|
2014-04-03 |
2015-10-08 |
Nektar Therapeutics |
Conjugués d'une fraction d'il-15 et d'un polymère
|
|
WO2015187295A2
(en)
|
2014-06-02 |
2015-12-10 |
Armo Biosciences, Inc. |
Methods of lowering serum cholesterol
|
|
IL254389B2
(en)
|
2015-03-11 |
2023-03-01 |
Nektar Therapeutics |
Polymer conjugates and the il–7 group
|
|
WO2016191587A1
(en)
|
2015-05-28 |
2016-12-01 |
Armo Biosciences, Inc. |
Pegylated interleukin-10 for use in treating cancer
|